WEST LAFAYETTE, Ind., May 25, 2023 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that Robert Leasure Jr., President and…Read More
Related Posts
Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability…
EAST RUTHERFORD, N.J, May 31, 2023 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug…
Recursion to Participate in Upcoming Investor Conferences Recursion Pharmaceuticals NASDAQRXRX
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion RXRX, a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor…
Repligen Announces Publication of the Companys 2022 Sustainability Report
WALTHAM, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2022 Sustainability Report…
